^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
OncoKey™ SL 525 Plus Assay

Company:
Luye Group
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
OncoKey SL 525 Plus targets 519 DNA genes (SNVs, small indels, CNV, MSI) and 87 RNA genes for fusion and splice variants. The assay also detects Oncogenic viruses. The OncoKey SL Plus panel is designed for pan cancer and covers genes associated with 12 different types of cancers.
Cancer:
Bladder Cancer, Breast Cancer, CNS Tumor, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Skin Cancer, Thyroid Gland Carcinoma
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A)
See More ...
Method:
Next-Generation Sequencing (NGS)